Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma

MELD Exceptions and Rates of Waiting List Outcomes

(2011) A. B. Massie et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

(2011) Khairuddin Memon et al.   GASTROENTEROLOGY

A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation

(2011) Michael D. Leise et al.   GASTROENTEROLOGY

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era

(2011) Carl L. Berg et al.   HEPATOLOGY

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (

(2011) Rita Golfieri et al.   HEPATOLOGY

Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy

(2011) Alessandro Cucchetti et al.   LIVER TRANSPLANTATION

Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System

(2010) K. Washburn et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Disparities in Liver Transplantation Before and After Introduction of the MELD Score

(2008) Cynthia A. Moylan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Analysis of longitudinal data to evaluate a policy change

(2008) Benjamin French et al.   STATISTICS IN MEDICINE